1995
DOI: 10.1172/jci118278
|View full text |Cite
|
Sign up to set email alerts
|

Potent inhibitory effects of transplantable rat glucagonomas and insulinomas on the respective endogenous islet cells are associated with pancreatic apoptosis.

Abstract: Effects of transplantable rat insulinomas (IN) and glucagonomas (GLU) on the endogenous pancreas were analyzed using morphometry, immunocytochemistry, in situ hybridization, and staining for apoptotic cells. Hyperinsulinemia (IN-rats) and hyper-GLP-1/glucagonemia (GLU-rats) were both associated with marked islet atrophy (67 and 76% of control average planimetrical islet area, respectively). Selective islet B cell inhibition of proinsulin (I and II) genes as well as of expression of the insulin gene transcripti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
61
1

Year Published

1996
1996
2009
2009

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 72 publications
(67 citation statements)
references
References 47 publications
5
61
1
Order By: Relevance
“…The reduction in transplanted beta-cell mass may be appropriate because islets transplanted to normoglycaemic recipients, either insulin-treated or normal mice, were not needed to maintain normoglycaemia, and theoretically could even put the recipients at risk for hypoglycaemia. In addition, the occasional hypoglycaemic episode detected in some insulin-treated mice may have accentuated the beta-cell mass reduction, since increased beta-cell death has been found in hypoglycaemic animals [33]. On the other hand, the beneficial effect of normoglycaemia on beta-cell survival recently reported by Davalli et al [32] in the first days after transplantation, may have palliated the initial beta-cell loss.…”
Section: Discussionmentioning
confidence: 94%
“…The reduction in transplanted beta-cell mass may be appropriate because islets transplanted to normoglycaemic recipients, either insulin-treated or normal mice, were not needed to maintain normoglycaemia, and theoretically could even put the recipients at risk for hypoglycaemia. In addition, the occasional hypoglycaemic episode detected in some insulin-treated mice may have accentuated the beta-cell mass reduction, since increased beta-cell death has been found in hypoglycaemic animals [33]. On the other hand, the beneficial effect of normoglycaemia on beta-cell survival recently reported by Davalli et al [32] in the first days after transplantation, may have palliated the initial beta-cell loss.…”
Section: Discussionmentioning
confidence: 94%
“…Total islet protein synthesis during culture was estimated by measuring L- [3, H]tyrosine incorporation (Amersham Biosciences, Amersham, UK) in trichloroacetic acid-precipitated protein extracts [14]. The acute glucoseinduced changes in mitochondrial membrane potential, intracellular Ca 2+ concentration ([Ca 2+ ] i ) and insulin secretion, as well as the islet insulin content after culture were measured as described [10].…”
Section: Methodsmentioning
confidence: 99%
“…Besides acutely regulating insulin biosynthesis and secretion, subacute and prolonged changes in nutrient availability exert pleiotropic effects on the beta cell phenotype, such as altered function, survival, growth and differentiation [3][4][5][6].…”
Section: Introductionmentioning
confidence: 99%
“…The NHI-cell system [18] is based on the prebeta-cell phenotype derived from the glucagon-producing MSL-G2 culture [29]. Following in vivo passage by transplantation in syngeneic NEDH rats, the pre-beta-cell phenotype (NHI-glu) matures into insulinomas [16,30]. Insulinomas reestablished in vitro display an insulin-producing beta cell phenotype (NHI-ins) for prolonged periods of time [31], closely resembling beta cells with respect to their mRNA expression profile [26].…”
Section: Methodsmentioning
confidence: 99%